ADVANCES IN ASTHMA MANAGEMENT IN PEDIATRICS

Asthma is a common condition affecting more than 300 million people around with an incidence rate of 5.3% in children. Asthma requires to be differentiated from other diseases like cystic fibrosis and bronchiectasis. As children have different bodily constitutions compared to adults, the guidelines for pharmacological therapy vary. The use of emerging therapy options eases the burden of emergency department visits. Thus, reviewing the latest advancements and therapy guidelines helps to reduce the associated morbidity and mortality.

Aim of the study: to review the latest methodology for the management of asthma in pediatric patients

Materials and methods: This review is a comprehensive search of PUBMED from the year 2014 to 2024.

Conclusion:Asthma is a disease with a multifactorial etiology, therefore there is a need for a multi-disciplinarian approach to reduce future morbidities in pediatric patients. There is a need for the establishment of recommendations for SMART therapy in children younger than 4 years and further study into the use of biologics.

Keywords: asthma; management; SMART therapy; biologics